Skip to main content

Table 2 Average Cost per DALY in relation to the null of interventions to reduce Colorectal Cancer in selected WHO subregions

From: Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis

  AFRE AMRA EURC
Intervention COST DALYS saved COST
per
DALY
COST DALYS
saved
COST
per
DALY
COST DALYS
saved
COST
per
DALY
  I$ (mill)   I$ I$ (mill)   I$ I$ (mill)   I$
Current Scenario (a) 116 27,546 4,206 64,937 14,135,241 4,594 4,677 1,801,461 2,596
FOB1 4,193 98,525 42,557 11,745 1,603,126 7,326 5,440 548,649 9,915
FOB2 2,222 66,502 33,410 6,448 1,082,872 5,954 2,954 370,055 7,984
SIG5 1,407 90,077 15,620 6,807 1,463,474 4,651 2,716 492,378 5,516
COL10 1,561 117,977 13,231 7,858 2,020,645 3,889 3,070 661,542 4,641
FOB1SIG5 4,915 121,374 40,491 15,989 1,969,383 8,119 7,069 665,773 10,617
FOB50 380 12,222 31,055 1,082 198,064 5,465 526 59,843 8,786
SIG50 531 41,910 12,669 2,446 679,950 3,597 984 205,514 4,786
COL50 1,040 91,092 11,415 5,027 1,491,646 3,370 1,980 449,523 4,404
FOBSIG50 478 46,981 10,183 3,032 762,325 3,977 860 230,391 3,734
RX 1,394 837,066 1,666 73,225 14,991,673 4,884 12,145 4,200,308 2,891
FOB1RX 5,461 912,458 5,984 77,579 16,300,533 4,759 16,481 4,630,614 3,559
FOB2RX 3,524 890,163 3,959 74,346 15,929,042 4,667 14,328 4,507,099 3,179
SIG5RX 2,706 896,387 3,019 75,839 15,864,896 4,780 14,100 4,518,157 3,121
COL10RX 2,844 909,822 3,126 76,031 16,131,444 4,713 14,301 4,604,861 3,106
FOB1SIG5RX 5,110 922,577 5,539 74,917 16,382,245 4,573 15,584 4,672,483 3,335
FOB50RX 1,758 850,239 2,067 74,130 15,200,680 4,877 12,633 4,275,966 2,954
SIG50RX 1,897 867,915 2,185 74,793 15,433,538 4,846 12,975 4,357,438 2,978
COL50RX 2,377 899,415 2,643 76,236 15,881,346 4,800 13,780 4,509,360 3,056
FOBSIG50RX 2,188 871,888 2,509 75,660 15,494,325 4,883 14,712 4,377,287 3,361
FVCAMP 275 7,618 36,074 366 84,085 4,354 360 17,804 20,222
FVCAMPRX 1,681 842,102 1,996 73,476 15,037,102 4,886 12,513 4,210,885 2,972
DRE1 818 9,438 86,676 2,370 153,861 15,401 1,008 52,939 19,038
DRE1RX 2,421 846,382 2,861 75,207 15,145,147 4,966 13,299 4,259,810 3,122
Cost-effective threshold    4,728    94,431    20,748
Very cost-effective threshold    1,576    31,477    6,916
  1. (Discounted at 3% per annum & Age-Weighted).
  2. Note: Interventions that fall on expansion path are in bold type.
  3. (a) The current scenario represents the interventions which are currently being provided in the sub-regions. This differs from the reference strategy, the null, where no intervention or treatment is provided.